These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4759918)

  • 1. Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia.
    Hruby MA; Schulman I
    Blood; 1973 Dec; 42(6):919-23. PubMed ID: 4759918
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
    Ruggeri ZM; Mannucci PM; Allain JP; Frommel D
    Ann N Y Acad Sci; 1975 Jan; 240():412-8. PubMed ID: 1053886
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 5. The suppression of factor VIII antibodies in haemophilia.
    Dormandy KM; Sultan Y
    Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilia with factor VIII inhibitor. Elimination of anamnestic response.
    Stein RS; Colman RW
    Ann Intern Med; 1973 Jul; 79(1):84-7. PubMed ID: 4124485
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide.
    Green D
    Blood; 1971 Apr; 37(4):381-7. PubMed ID: 5549716
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful management of a subdural hematoma in a hemophiliac with an anti-factor VIII antibody.
    Edson JR; McArthur JR; Branda RF; McCullough JJ; Chou SN
    Blood; 1973 Jan; 41(1):113-22. PubMed ID: 4682073
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII inhibitors, natural history and management.
    Allain JP
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):241-2. PubMed ID: 524148
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII inhibitors in hemophilia.
    Mariani G
    Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
    Nilsson IM; Berntorp E; Zettervall O
    N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic inhibitor of factor VIII and its treatment by immunosuppression.
    Ting HC; Wang F; Por P; Nurulhuda A
    Acta Haematol; 1980; 64(4):236-8. PubMed ID: 6781207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX.
    Nilsson IM; Hedner U
    Scand J Haematol; 1976 May; 16(5):369-82. PubMed ID: 951577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia: acquired modifications of the genetic disorder.
    Hampton JW; Warner D
    Ann N Y Acad Sci; 1975 Jan; 240():405-6. PubMed ID: 1053884
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of immunosuppression in a severe haemophilia B patient with specific antibody.
    Allain JP; Frommel D
    Thromb Haemost; 1976 Aug; 36(1):86-9. PubMed ID: 1036830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the hemophiliac with anti-VIII.
    Lewis JH; Oskins PB
    Ann N Y Acad Sci; 1975 Jan; 240():407-11. PubMed ID: 1053885
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide.
    Hedner U; Tengborn L
    Thromb Haemost; 1985 Dec; 54(4):776-9. PubMed ID: 3937274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Hemophilia: cyclophosphamide and factor VIII concentrate.
    Stein RS
    Ann Intern Med; 1974 Nov; 81(5):706-7. PubMed ID: 4419955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.